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Abstract
The incorporation of the envelope glycoprotein complex (Env) onto the developing particle is a crucial step in the HIV-1
lifecycle. The long cytoplasmic tail (CT) of Env is required for the incorporation of Env onto HIV particles in T cells and
macrophages. Here we identify the Rab11a-FIP1C/RCP protein as an essential cofactor for HIV-1 Env incorporation onto
particles in relevant human cells. Depletion of FIP1C reduced Env incorporation in a cytoplasmic tail-dependent manner,
and was rescued by replenishment of FIP1C. FIP1C was redistributed out of the endosomal recycling complex to the plasma
membrane by wild type Env protein but not by CT-truncated Env. Rab14 was required for HIV-1 Env incorporation, and
FIP1C mutants incapable of binding Rab14 failed to rescue Env incorporation. Expression of FIP1C and Rab14 led to an
enhancement of Env incorporation, indicating that these trafficking factors are normally limiting for CT-dependent Env
incorporation onto particles. These findings support a model for HIV-1 Env incorporation in which specific targeting to the
particle assembly microdomain on the plasma membrane is mediated by FIP1C and Rab14.
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Introduction
HIV-1 particles assemble on the plasma membrane of infected
human cells. The underlying shell of the developing viral particle is
formed by the Pr55Gag polyprotein (Gag), which is translated deep
within the cytoplasm of cells and reaches the plasma membrane by
an unknown mechanism [1,2,3]. Gag binds to the viral genomic
RNA through its nucleocapsid (NC) region and is responsible for
packaging of RNA into the developing particle. A -1 ribosomal
frameshift results in the formation of the Gag-Pol precursor
protein in a molar ratio of 20:1 Gag to Gag-Pol [4]. Gag, Gag-Pol,
and the associated viral genomic RNA traffic together to the
particle assembly site on the plasma membrane. The envelope
glycoprotein complex (Env) of HIV-1 is simultaneously incorpo-
rated onto the lipid membrane of the developing particle, and yet
must travel via a very different route to reach the assembly site.
Env is synthesized on ribosomes associated with the endoplas-
mic reticulum as a precursor protein, gp160 [5]. Trimerization of
gp160 is required for exit from the ER [6]. During transit through
the Golgi, gp160 becomes heavily glycosylated and the precursor
subunits are cleaved by furin-like proteases to create gp41 (TM)
and gp120 (SU) subunits. A trimer of heterodimers of TM and SU
forms the functional Env glycoprotein complex. Once the mature
complex reaches the cell surface, it is either incorporated onto
budding virions or rapidly internalized [7,8,9,10]. In contrast to
the dense concentration of envelope glycoprotein spikes on the
surface of orthomyxoviruses [11], paramyxoviruses [12], herpes-
viruses [13], and the relative abundance of envelope spikes on
gammaretroviruses [14], lentiviral particles incorporate a very
limited number of envelope proteins. Estimates from electron
tomography studies reveal an average of 8–14 trimers per virion
particle when virions with full-length HIV envelopes are examined
[15,16]. SIV strains with truncations in the cytoplasmic tail (CT)
have been noted to incorporate 70–79 trimers and have been
widely employed in cryoEM studies of the envelope spike
[15,16,17]. The reasons for the paucity of Env trimers on
lentiviral particles in the absence of mutant CT domains remain
unknown.
HIV and SIV Env proteins incorporate long CTs, averaging
about 150 amino acids in length. The Env CT has been the subject
of numerous studies, yet a complete understanding of how the CT
mediates incorporation onto budding virions remains elusive. The
Env CT includes a membrane-proximal YXXwmotif that mediates
clathrin- and AP2-dependent endocytosis [8,9,18,19,20] and a
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number of additional tyrosine-based and dileucine motifs that have
been implicated in endocytosis and trafficking of Env [21]. A YW802
motif was reported to interact with TIP47, and by this interaction
mediate Env interaction with Gag and incorporation onto particles
[22]. Murakami and Freed reported that the long CT of Env is
required for particle incorporation into virions and for viral
replication in T cell lines and primary cells [23]. This report
established the cell type-specific, tail-dependent incorporation onto
virions, suggesting that host factors may mediate Env incorporation
and be differentially expressed in distinct cell types.
The Rab11a Family Interacting Proteins (FIPs) are effector
molecules that bind Rab11 family members and mediate sorting of
cargo from the endosomal recycling compartment to the plasma
membrane [24,25]. We evaluated Rab11-FIPs as potential
mediators of HIV-1 Env incorporation into particles. We
identified Rab11-FIP1C/RCP as a specific host cellular factor
mediating the delivery of HIV-1 Env onto virion particles in a CT-
dependent manner. FIP1C-dependent Env incorporation was not
mediated through interaction with Rab11a, but instead required
interaction with Rab14.
Results
The limitation to virion Env incorporation is cytoplasmic
tail-dependent
The limited number of Env trimers on HIV-1 particles
suggested to us that there is an inherent limitation to Env
incorporation that is unrelated to the production of Env protein in
the cell. To directly test this hypothesis, we expressed a constant
amount of Gag expression plasmid together with an increasing
amount of full-length or cytoplasmic tail-truncated Env. We used
the CTdel-144 Env (CT144) [23], which retains only 6
cytoplasmic residues of the tail, in order to determine if the
cytoplasmic tail was important in limiting the amount of Env on
the particle. Expression of full-length Env in cells increased
sequentially with increasing amount of plasmid transfected. The
amount of Env on released HIV-1 particles did not continue to
increase, however, but instead reached a plateau at levels of 0.8 mg
or more of transfected DNA (Fig. 1A, WT Env). CT144
expression in cells increased similarly, but incorporation onto
HIV-1 particles continued in a linear fashion without apparent
saturation (Fig. 1A, CT144). The saturation of full-length Env
incorporation was further documented by quantitation of Env/
Gag ratio in released particles as measured by densitometry
(Fig. 1B) or by gp120 and p24 ELISA (Fig. 1C). We confirmed that
the pelletable Env observed in these experiments was particle-
associated and not due to overexpression of Env and release on
microvesicles (Fig. S1). Despite the ability to incorporate Env at
higher levels upon overexpression, particles bearing CT144 Env
were consistently less infectious as measured using TZM-bl
indicator cells (Fig. 1D). A plateau in particle infectivity conferred
by WT Env was noted at the same level of Env expression found to
be saturating by Western blot or ELISA analysis (Fig. 1D). These
results indicated to us that the cytoplasmic tail of Env confers a
limitation to Env trimer incorporation onto HIV-1 particles.
Rab11-FIP1C is required for Env incorporation onto
virions
Saturation of Env on HIV particles could be due to limiting
concentrations of a cellular factor that is required for its trafficking
or incorporation. We initially investigated a variety of factors
involved in cellular recycling pathways as candidates. Depletion of
Rab11a or Rab11b did not significantly diminish Env on particles,
yet overexpression of the active, GTP-bound form of Rab11a
(Rab11a S20V) diminished cellular and particle-associated Env
(Fig. S2). This led us to consider the Rab11 Family Interacting
Proteins (Rab11-FIPs) as candidates involved in HIV-1 Env
trafficking, reasoning that one of the FIPs may have been saturated
by Rab11 S20V overexpression. The Rab11-FIPs were originally
identified in a yeast 2-hybrid screen using Rab11aS20V as bait
[24]. Rab11-FIPs form parallel coiled-coil homodimers and bind
to two Rab11a-GTP molecules, creating a heterotetrameric
complex that regulates distinct intracellular membrane trafficking
events. To examine the potential involvement of the Rab11-FIPs
in Env trafficking, we performed shRNA-mediated depletion of
each of the described FIPs in HeLa cells. Cells were transfected
with NL4-3 proviral DNA and analyzed for particle output, Env
content, and infectivity of the released particles. Knockdown
efficiency was assessed by real-time PCR, and varied from 65–
90% by this assay (Fig. 2A). A striking phenotype was observed in
this experiment. Depletion of FIP1C led to markedly diminished
particle infectivity, while little effect was seen with depletion of
FIP2, FIP3, FIP4, or FIP5 (Fig. 2A). We next verified the
knockdown of FIP1C using specific antisera, and examined
cellular and viral levels of Env (Fig. 2B). Notably, the cellular
levels of gp160 were not altered by FIP1C depletion, while
particle-associated Env was markedly lower. Both gp120 and gp41
levels were diminished, suggesting a defect in Env heterotrimer
incorporation rather than simply induced shedding of gp120
(Fig. 2B). While depletion of FIP1C removed Env from particles, it
had no effect on cellular Env production or on the release of
particles (CA bands, Fig. 2B).
The striking effect of FIP1C depletion on Env incorporation
suggested to us that it might be an essential cofactor for Env
trafficking and particle incorporation. However, to rule out off-
target effects, we next restored cellular levels of FIP1C using an
shRNA-resistant GFP-tagged FIP1C cDNA. Fig. 2C demonstrates
that FIP1C depletion and not transduction with a scrambled
shRNA vector depleted cellular FIP1C levels and diminished
particle Env incorporation. FIP1C levels were not restored upon
expression of the unaltered FIP1C cDNA. In contrast, expression
of FIP1C cDNA with silent mutations rendering it resistant to
shRNA-mediated depletion was able to fully restore the incorpo-
ration of Env onto HIV-1 particles (Fig. 2C, FIP1C cDNA* lanes).
Accompanying the restoration of FIP1C function and Env
incorporation, the infectivity of the released particles was fully
restored (Fig. 2D).
Author Summary
Enveloped viruses must develop strategies to ensure that a
sufficient quantity of their receptor-binding envelope
proteins are incorporated onto the surface of viruses as
they form. The HIV envelope glycoprotein is specifically
incorporated onto assembling virions in relevant cells such
as T lymphocytes in a manner that requires its long
cytoplasmic tail. The mechanism underlying this specific
incorporation has remained unknown. Here, we identify a
cellular trafficking pathway that is required for the
incorporation of HIV envelope onto virions. A combination
of the adaptor protein Rab11-FIP1C and Rab14 directs the
envelope protein onto assembling virions, and loss of
either of these host factors results in the production of
virus particles lacking envelope. We also found that FIP1C
was required for replication in T cell lines. This study
identifies a trafficking complex required for HIV envelope
incorporation and for the formation of infectious HIV
particles.
FIP1C and Rab14 Direct HIV-1 Env Incorporation
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Figure 1. The incorporation of Env onto HIV-1 particles is saturable in a cytoplasmic tail-dependent fashion. (A) Increasing amount of
wildtype and the tailless mutant (CT144) of NL4-3 Env protein expressing plasmids were co-transfected with fixed amount of pNL4.3Env- proviral
plasmid into HeLa cells. Progeny viral particles were harvested two days after transfection through a 20% sucrose cushion and the particles were
lysed with SDS loading buffer. Proteins were analyzed by immunoblot using Env and CA specific antibodies. (B) The intensity of each Env band and
Gag band in the particle immunoblot shown in A was quantified by Licor software. Background-subtracted pixel intensity values were plotted on the
graph as Env band intensity versus CA band intensity. (C) The absolute quantity of Env and CA/P24 on particles was measured by gp120 ELISA and
p24 ELISA. The number of Env molecules per particle was calculated as an approximation, assuming that 5000 CA molecules are present in one HIV-1
virion. (D) The infectivity of the progeny viral particles was measured using TZM-bl reporter cells. Infectivity is plotted as number of blue cells per
nanogram of p24 antigen used in the infection assay.
doi:10.1371/journal.ppat.1003278.g001
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Figure 2. FIP1C depletion and HIV-1 Env incorporation in HeLa cells. (A) The efficiency of depletion of Rab11a-FIPs was measured by real
time PCR (top). Infectivity of released particles following depletion of each FIP family member is shown below. (B) Depletion of FIP1C was confirmed
at the protein level by immunoblotting with a FIP1C-specific antiserum. Env levels in both cell lysates and virions harvested from the FIP-depleted
HeLa cells were assayed by immunoblotting. (C) Restoration of Env incorporation following shRNA-mediated depletion. Two constructs were used in
this experiment: FIP1C cDNA is an shRNA sensitive GFP-tagged plasmid; while FIP1C* includes silent mutations in the shRNA target sequence
rendering it shRNA-resistant. 2 ug and 4 ug of each FIP1C construct were used in the repletion assay as indicated at the top of the blot. (D) Infectivity
of viral particles from the experiment shown in panel D as evaluated using TZM-bl indicator cells. Lanes are numbered and correspond to the blot
above. Statistical comparisons utilized the unpaired t-test, * = p,.05; ** = p,.01.
doi:10.1371/journal.ppat.1003278.g002
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Rab11-FIP1C mediates Env incorporation in T cell lines
We next examined the effect of FIP1C depletion on truncated
Env using NL4-3delCT144, and extended our analysis to the H9
T cell line. In HeLa cells, depletion of FIP1C markedly diminished
Env incorporation in released particles as before (Fig. 3A, WT
lanes). CT144 Env incorporation was not altered by depletion of
FIP1C (Fig. 3A, CT144 lanes). The effect of FIP1C depletion was
even more striking when the experiment was performed in H9
cells (Fig. 3A, H9 particle lanes). CT144 was very poorly
incorporated in control-transduced cells in H9 cells, reflecting
cytoplasmic tail-dependent particle incorporation of Env as had
been reported [23]. The small amount of incorporated CT144
Env was not altered by FIP1C depletion (Fig. 3A). Particle
infectivity measured in supernatants from wildtype NL4-3 virus
was diminished upon FIP1C depletion in both HeLa and H9 cells,
while NL4-3delCT144 particle infectivity was not altered (Fig. 3B).
Notably, the effect of FIP1C depletion on HIV-1 Env incorpo-
ration was specific for HIV, as no effect on Env incorporation or
particle infectivity was observed for viruses pseudotyped with
VSV-G or the amphotropic murine leukemia virus (MLV) Env
(Fig. S3).
FIP1C depletion reduces cell surface concentration of
HIV-1 Env and inhibits viral replication in T cell lines
FIP1C is involved in directed trafficking of membrane proteins
from the endosomal recycling complex to the plasma membrane.
We hypothesized that FIP1C depletion would diminish the specific
outward trafficking of HIV-1 Env from this compartment. Cell
surface Env was measured in control H9 cells versus those
depleted of FIP1C. Cell surface gp120 levels were significantly
diminished following FIP1C depletion, while total cellular levels of
Env were comparable in control and FIP1C-depleted cells (Fig. 3C
and 3D, WT). In contrast, no significant effect on cell surface levels
of CT144 Env was observed following FIP1C depletion (Fig. 3C
and 3D, CT144). We conclude from this that there is a partial
depletion of cell surface Env following FIP1C/RCP depletion, and
this depletion is itself dependent upon an intact cytoplasmic tail.
We next established a population of H9 cells depleted for FIP1C,
and infected this population with NL4-3 virus or NL4-3delCT144
at a multiplicity of infection (MOI) of 0.5. No replication of the
cytoplasmic tail-truncated virus was observed in H9 cells (Fig. 3E,
closed triangles). Wildtype NL4-3 replicated well in H9 cells that
had been transduced with control shRNA (filled squares, Fig. 3E).
Depletion of FIP1C resulted in markedly delayed and slow
replication of NL4-3 (Fig. 3E). At late timepoints, this virus was
able to replicate more efficiently, and this was associated with
higher levels of FIP1C that developed in the H9 population over
time, and not with viral reversion to a FIP1C-independent state
(not shown). We concluded from this that FIP1C was essential for
Env incorporation and for viral spreading infection.
Redistribution of FIP1C to the plasma membrane by HIV-
1 Env
FIP1C normally resides in a perinuclear compartment that
colocalizes strongly with Rab11a [26]. HIV-1 Env is found
extensively in intracellular compartments as well as on punctate
foci on the plasma membrane, making studies of surface
redistribution of Env by cellular factors challenging. However,
we reasoned that Env might redistribute GFP-FIP1C in a
measurable manner. GFP-FIP1C was found predominantly in a
focal perinuclear location in HeLa cells in the absence of HIV-1
Env expression (Fig. 4A). Transfection of NL4-3 provirus led to a
marked redistribution of GFP-FIP1C to intracellular vesicles and
to the plasma membrane (Fig. 4B). The redistribution of GFP-
FIP1C out of the perinuclear compartment was especially evident
in fields where cells expressing Env were adjacent to those lacking
Env (Fig. 4C). In contrast, transfection of NL4-3delCT144
provirus in general retained the perinuclear distribution of GFP-
FIP1C (Fig. 4D). The differences in redistribution of FIP1C out of
the perinuclear location were scored by a blinded observer and
were significantly different for WT vs. CT144 provirus (Fig. 4E).
To determine if this effect was due to Env alone and not to other
components of the provirus, the experiment was repeated with
expression of WT Env and CT144 Env alone. Again the
peripheral redistribution of FIP1C by WT Env was noted, with
a much lower level of FIP1C outside of the perinuclear region
upon expression of CT144 Env (Fig. 4F). Differences in FIP1C
distribution between full-length and CT144 Env were statistically
significant (p,0.001 by chi squared test). These results suggest a
CT-dependent outward movement of FIP1C.
Mapping the interaction between FIP1C and Rab14
While FIP1C was critical to Env incorporation onto particles,
depletion of Rab11 itself did not significantly alter Env incorpo-
ration (discussed further below). To reconcile how a Rab11a-
binding protein acting as an adaptor could modulate Env
incorporation in a Rab11a-independent manner, we investigated
the involvement of Rab14 in Env incorporation. Rab14 has
recently been identified as a Rab11-FIP binding protein [27].
These investigators had suggested that Rab14 might interact with
the Rab binding domain of multiple Rab11-FIP proteins. We
therefore sought to investigate the association of Rab14 with
different Rab11-FIPs using a split-ubiquitin yeast two-hybrid assay
as a method for assessing protein interactions. While we did
confirm that Rab14 interacted with FIP1C as well as FIP1B, we
did not find any interaction with FIP2 (Supplemental Table S1 in
Text S1). All three Rab11-FIP proteins interacted with Rab11a,
but none interacted with Rab8a. Given these results, we next
evaluated whether Rab14 associated in situ with FIP1C. Fig. 5A
demonstrates that GFP-FIP1C colocalized extensively with both
Rab11a and Rab14 in a concentrated compartment representing
the ERC. However, FIP1C(1–614), which lacks a Rab11a binding
domain was distributed throughout the cytosol rather than
concentrated in the ERC, and did not colocalize with either
Rab11a or Rab14 (Fig. 5B). The carboxyl terminal truncation
Rab11-FIP1C(560–649) caused a marked concentration of both
Rab11a and Rab14 with the dominant negative construct
(Fig. 5C). Nevertheless, while GFP- FIP1C(592–649), which
retains the Rab11-binding domain, did colocalize extensively with
Rab11a, the localization with Rab14 was markedly attenuated
(Fig. 5D). These results suggested that Rab14 may not be
associating with the Rab11-binding domain as suggested by Kelly
at al. (2010). Since Kelly et al. (2010) had suggested that Rab14
associated with other Rab11-FIP proteins through their conserved
Rab11-binding domains, we next examined the association of
Rab14 with the dominant negative trafficking mutant GFP-
FIP2(129–512). While this mutant strongly concentrated Rab11a,
it had no effect on Rab14 distribution (Fig. S4). Similarly, we did
not observe any effects of a carboxyl terminal fragment of FIP5 on
Rab14 distribution, although it did strongly concentrate Rab11a
(data not shown). These immunofluorescence studies, combined
with yeast two-hybrid results, indicated that Rab14 is not
interacting with the Rab binding domain of Rab11-FIP1C, since
this helix is strongly conserved in all FIP proteins.
To evaluate further the binding requirements for Rab14 with
FIP1C, we compared the sequences of FIP1C and FIP2 in their
carboxyl termini and performed directed mutagenesis of candidate
FIP1C and Rab14 Direct HIV-1 Env Incorporation
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Figure 3. FIP1C depletion alters HIV-1 Env incorporation, cell surface levels, and viral growth in the H9 T cell line. (A) FIP1C depletion
was achieved using shRNA in HeLa cells (left) and the H9 T cell line (right). Populations of FIP1C-depleted HeLa and H9 cells were then divided and
infected with VSV-pseudotyped NL4-3 or NL4-3delCT144. Released viruses were harvested 2 days after infection (HeLa) or 4 days after infection (H9)
and evaluated for protein content by Western blotting. Note that results using specific antiserum used for detection of gp120 and gp160 in cells and
FIP1C and Rab14 Direct HIV-1 Env Incorporation
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residues that were different between the two Rab11-FIPs. We
mutated two residues from FIP1C to those matching the sequence
in FIP2 to create FIP1C(S580N/S582L). Fig. 5E shows that this
double mutation in the context of GFP-FIP1C(560–649) elicited a
loss of colocalization with Rab14, while colocalization with
Rab11a was unaffected. These results demonstrate that the region
proximal to the Rab11-binding domain in FIP1C is responsible for
association with Rab14, separate from the Rab11a association
requirements. We next confirmed direct binding of WT GFP-
FIP1C but not GFP-FIP1C(S580N/S582L) with Rab14 through
co-immunoprecipitation studies (Fig. S5). Having mapped the
Rab14 binding domain on FIP1C, we next asked if the Rab14-
FIP1C interaction was responsible for the FIP1C-dependent
incorporation of Env onto HIV-1 particles.
Rab14 mediates HIV-1 Env incorporation onto HIV-1
particles
Based on the interaction between FIP1C and Rab14, we
considered the possibility that Rab14 is involved in HIV-1 Env
trafficking and incorporation onto HIV particles. We first
examined the effects of dominant-negative (S25N) and constitu-
tively-active (Q70L) forms of Rab14 on incorporation of HIV-1
Env. Remarkably, dominant-negative Rab14(S25N) diminished
the incorporation of Env onto HIV-1 particles in a dose-
dependent fashion (Fig. 6A). Constitutively-active Rab14(Q70L)
expression had the opposite effect, and resulted in an enhanced
level of particle-incorporated Env (Fig. 6A, Rab14Q70L). These
results supported an important role for Rab14 in HIV-1 Env
incorporation. In the absence of FIP1C, the enhancement of
particle-incorporated Env by Rab14(Q70L) was not observed (Fig.
S6A). Consistent with our prior findings of CT-dependence,
Rab14 constitutively-active and dominant-negative constructs had
no effect on incorporation of CT144 Env onto particles (Fig. 6A,
rightmost panels). Combined with the interaction mapping data
above, these data strongly suggest that an interaction between
FIP1C and Rab14 is required for incorporation of full-length
HIV-1 Env onto particles.
To evaluate further the role of Rab14 on Env incorporation, we
depleted Rab14 or Rab11a in HeLa cells using shRNA and
compared the effects on Env incorporation. Rab14 depletion, but
not Rab11a depletion, diminished HIV-1 Env incorporation
(Fig. 6B). The effect of Rab14 depletion was specific for HIV-1
Env, as it had no effect on pseudotyping of HIV particles with
VSV-G or amphotropic MLV Env (Fig. S6B). To further examine
the specificity of the Rab14-FIP1C interaction in mediating HIV
Env incorporation, we utilized the interaction domain mapping
data outlined above, and asked if FIP1C(S580N/S582L), which
does not interact with Rab14, could rescue Env incorporation in
FIP1C-depleted HeLa cells. Strikingly, shRNA-resistant wildtype
FIP1C rescued Env incorporation as before, while the 580/582
double mutant was unable to rescue Env onto particles (Fig. 6C,
compare lanes 3 and 4 to lanes 5 and 6). This indicates that Rab14
interaction is required for rescue of Env particle incorporation. We
then introduced mutations in the Rab11 binding domain that have
been shown to eliminate Rab11a binding and disrupt membrane
association (FIP1C(I621E)) or that eliminate Rab4 interactions
without disrupting membrane interactions (FIP1C(D622N)) [28],
placing these both in the context of the shRNA-resistant FIP1C
construct. When compared head-to-head, FIP1C(I621E) was not
able to rescue Env particle incorporation (Fig. 6C, lane 7) while
FIP1C(D622N) was competent for rescue (Fig. 6C, lane 8). We
interpret this to mean that mislocalized I621E does not reach the
ERC, and subsequently cannot direct outward sorting of Env. It is
unclear whether this means that normally Rab11 binding is
required for the initial ERC localization of FIP1C, followed by
Rab14-directed outward sorting, or if the mislocalization and lack
of rescue of Env incorporation is reflective of other defects elicited
by this mutation. The fact that knockdown of Rab11a or Rab11b
did not alter Env incorporation (Fig. S2A) suggests the latter
interpretation, but further work will be needed to define this.
Taken together, our data support a model in which a specific
Rab14/FIP1C complex mediates the intracellular trafficking and
particle incorporation of the HIV-1 Env glycoprotein complex.
FIP1C mediates Env incorporation in primary human
macrophages
Cytoplasmic tail-dependent incorporation of HIV-1 Env onto
HIV particles is not limited to T cells, but also has been
demonstrated in monocyte-derived macrophages (MDMs) [23].
We therefore sought to determine if FIP1C-dependent Env
incorporation was also present in MDMs. Using an efficient
siRNA method we recently established in MDMs [29], we
depleted FIP1C in primary MDMs from two donors, then infected
the cells with VSV-G-pseudotyped wildtype NL4-3 or NL4-
3delCT144. As expected, incorporation of gp120 and truncated
gp41 on particles from NL4-3delCT144-infected cells was
markedly lower than wildtype NL4-3 (Fig. 7A). Depletion of
FIP1C in MDMs significantly diminished gp41 and gp120 particle
incorporation (Fig. 7A) and infectivity (Fig. 7B). These data
indicate that FIP1C is required for the CT-dependent incorpo-
ration of Env onto HIV particles in MDMs as it is in T cell lines
and HeLa cells.
FIP1C and Rab14 overexpression enhances Env
incorporation in HeLa cells
Our initial rationale for searching for cellular trafficking factors
involved in Env incorporation was the fact that limitations to Env
particle incorporation were not related to the amount of Env
produced in infected or transfected cells (Fig. 1). After identifying
the involvement of FIP1C and Rab14 in Env incorporation, we
wished to determine if overexpression of FIP1C and Rab14 would
therefore overcome this limitation and significantly enhance Env
incorporation. We created a cell line that inducibly overexpressed
FIP1C and Rab14Q70L, and repeated the titration of Env
expression in the presence of a constant amount of cellular Gag.
Remarkably, the expression of FIP1C and Rab14Q70L enhanced
Env incorporation by 2–3 fold (Fig. 7C). Cell surface levels of Env
were also increased upon overexpression of FIP1C and
Rab14Q70L as assessed by a surface biotinylation assay (Fig. 7C,
bottom). The increase in Env incorporation on particles released
particles are shown; gp41 particle blots were probed with a gp41-specific monoclonal antibody. (B) Infectivity of released viral particles from the
experiment shown in (A) was measured in the TZM-bl reporter cell line, expressed as infectious units/ng p24. (C) Plasma membrane (left) and total
cellular (permeabilized) levels of HIV-1 Env (right) were detected using flow cytometry 4 days after infection with VSV-G- pseudotyped NL4-3 WT or
NL4-3delCT144 viruses. The relative level of Env on plasma membrane compared to total Env was calculated and plotted in panel (D) for control and
FIP1C-depleted H9 cells. (E) FIP1C-depleted (open circles) and control shRNA-treated H9 cells (filled squares) were infected with VSV-pseudotyped
viruses indicated at MOI 0.5. Viral growth was monitored over time by detection of p24 in the culture supernatant. CT144 growth (triangles) shown in
control H9 cells.
doi:10.1371/journal.ppat.1003278.g003
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Figure 4. HIV-1 Env redistributes FIP1C to plasma membrane in a gp41 cytoplasmic tail-dependent manner. HeLa cells were
transfected with GFP-FIP1C (A–C) and either proviruses NL4-3 WT Env (B,C) or NL4-3delCT144 Env mutant (D). 24 hours after transfection, cells were
fixed with 4% PFA and stained for HIV-1 Env using human monoclonal antibody b12. The distribution of GFP-tagged FIP1C, FIP2 and Env was
examined using a wide-field deconvolution immunofluorescent microscope. Quantitation of tight perinuclear distribution versus peripherally-
distributed GFP-FIP1C was evaluated by blinded observers on a per-cell basis, presented graphically as the % of evaluable cells in each category (E).
We also tested if HIV-1 Env protein alone redistributes FIP1C using same method described above and plotted the result in (F).
doi:10.1371/journal.ppat.1003278.g004
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from this cell line was quantified by densitometric evaluation of
Env/Gag ratios and by determination of Env and Gag particle
content by ELISA (Fig. 7D). We conclude that FIP1C and Rab14
are limiting factors for Env particle incorporation in HeLa cells.
Discussion
Retroviral envelope proteins are incorporated onto developing
viral particles by a process that remains incompletely understood.
Pseudotyping of viruses or virus-like particles (VLPs) with envelope
glycoproteins of foreign viruses has revealed both specific and non-
specific mechanisms of Env incorporation. HIV-1 can form
infectious particles with Env proteins from a wide variety of
retroviral subfamilies, including alpha-, beta-, gamma-, and delta-,
and even spumaretroviruses [30,31,32,33,34] (reviewed in [35]).
This promiscuity for pseudotyping extends to Env glycoproteins
from other viral families, including coronaviruses [36], paramyxo-
viruses [37], filoviruses [38], rhabdoviruses [39], and others.
Promiscuity of Env incorporation would argue either for a lack of
specificity of Env incorporation, or for a common mechanism that
Figure 5. GFP-FIP1C-wildtype and FIP1C truncation mutants demonstrate distinct localization with Rab14 and Rab11a. HeLa cells
were transfected with (A)GFP- FIP1C wild-type (WT; 1–649), (B) C-terminally truncated GFP-FIP1C (1-614), lacking the Rab11 binding domain (RBD), (C)
N-terminally truncated GFP-FIP1C (560–649), (D) GFP-FIP1C (592–649), or (E) FIP1C(560–649)(S580N/S582L). Cells were fixed and stained for
endogenous Rab14 (red) and Rab11a (blue).
doi:10.1371/journal.ppat.1003278.g005
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Figure 6. Rab14 interaction with FIP1C is required for HIV-1 Env incorporation. (A) HeLa cells were transfected with proviral plasmid pNL4-
3 or NL4-3 CT144 and either a dominant negative form of Rab14 (Rab14S25N) or a constitutively active form of Rab14 (Rab14Q70L). 48 hours after
transfection, cellular and particle content of HIV-1 Env was examined by Western blot. Numbers above Env blots represent densitometry values with
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is shared by these diverse viruses for Env delivery and
incorporation. In contrast, HIV-1 Env itself is quite selective in
its ability to pseudotype other retrovirus particles. HIV-1 Env with
a full length CT is unable to pseudotype MLV vectors, although
truncation of Env CT allows MLV pseudotyping [40]. HIV-1
mutants with point mutations in MA fail to incorporate full-length
HIV-1 Env, while truncation of CT allows Env incorporation
[41,42]. Although direct interactions between Env CT and MA
have been reported in vitro for HIV and SIV [43,44], a direct
interaction has been difficult to substantiate in cell-based assays.
Thus there is selectivity and specificity of particle incorporation
that is conferred by the full length HIV-1 Env CT, while the
mechanism has not yet been fully explained. The specificity of
HIV-1 Env incorporation could be due to direct interactions with
MA, to indirect Gag-Env interactions mediated by an intermedi-
ate host protein, or could be explained by cotrafficking to a
common site of assembly as outlined by Jorgenson and colleagues
[45]. Our data support a requirement for specific outward Env
trafficking from the ERC mediated by FIP1C and Rab14.
Functionally, the Rab11-FIPs play important roles in the
recycling of cargo from the recycling system to the cell surface.
Rip11/Rab11-FIP5 is required for the transport of GLUT4
vesicles to the cell surface following insulin treatment [46]. FIP2
regulates the recycling of a number of plasma membrane proteins,
including aquaporin-2 and CXCR2, to the cell surface [47,48].
FIP2 has also been implicated in trafficking and assembly of
respiratory syncytial virus, providing prior evidence that viruses
may usurp the FIP-mediated transport mechanisms to deliver their
cargo to the site of assembly [49]. Most significant for this report is
the ability of FIP1C to regulate the recycling of a5b1 integrin and
EGFR1 to the cell surface [50].
We identified FIP1C and its binding partner Rab14 as essential
components determining the incorporation of full-length but not
truncated Env onto HIV-1 particles. Rab11-FIP1 was first
identified in 2001 through a yeast 2-hybrid screen employing
dominant active Rab11a as bait [24]. Rab11a and Rab11-FIPs
localize to the endosomal recycling complex and to the apical
recycling endosome in polarized cells, where they regulate sorting
and plasma membrane recycling [25,26]. There are five members
of this family that have been divided into two classes based upon
the presence of specific motifs including C2 domains (class 1
members FIP1B, FIP1C, FIP2, and Rip11/FIP5) and EF hands
(class 2 members FIP3 and FIP4) [25,51]. All family members
possess a carboxyl-terminal alpha-helical Rab11-binding domain
(RBD). The RBD of the FIPs forms a parallel coiled-coil
homodimer that interacts with switch 1 and switch 2 regions of
the GTP-bound form of Rab11a, resulting in a heterotetrameric
complex of two FIPs and two Rab proteins [52,53,54,55]. While a
previous investigation has suggested that the class I FIPs are
capable of forming complexes with the Rab14 GTPase [27], our
findings suggest that Rab14 interacts specifically with FIP1C
through a region separable from the Rab11 binding domain.
These results indicate that FIP1C has multiple binding domains
for small GTPases, as previously demonstrated for Rabaptin-5
(Rab5 and Rab4) and FIP3 (Arf6 and Rab11) [29,56]. Our studies
demonstrate the discrete point mutations in FIP1C proximal to the
RBD can disrupt Rab14 binding without affecting Rab11a
association. Similarly, we could not demonstrate any association
between Rab14 and FIP2 or FIP5 in either split ubiquitin yeast
two-hybrid assays or in immunofluorescence studies. The differ-
ence between our studies and those of Kelly, et al. (2010) could be
due to differences in the cell systems examined, but it seems more
likely that the discrepancy stems from the antibodies used to detect
Rab14. The Aviva Rab14 antibody we have used here has no
cross reactivity with either Rab11a or Rab7. In contrast, we have
found that the antibody used by Kelly, et al. [27] has prominent
cross-reactivity with recombinant Rab11a and Rab7 (data not
shown). In any case, the fact that the S580N/S582L FIP1C dual
mutant was unable to rescue Env particle incorporation confirms
that it is the Rab14/FIP1C interaction rather than the interaction
of Rab11a with FIP1C that defines the trafficking complex for
HIV Env. In support of this, we found that the GTP-bound form
of Rab14(Q70L) actually enhanced the amount of particle-
associated Env, while dominant-negative Rab14(S25N) diminished
Env incorporation in a dose-dependent fashion. Similar experi-
ments with dominant-negative and constitutively-active Rab11a
did not demonstrate this effect. In fact, the constitutively-active
Rab11a(S20V) construct diminished Env incorporation, perhaps
through competition for FIP1C binding. Together, our results
support a complex of GTP-bound Rab14 and FIP1C as essential
components mediating the transport of HIV-1 Env to the particle
assembly site.
Our data support a model of directed outward trafficking of
HIV-1 Env to a plasma membrane microdomain for specific
incorporation onto the lipid envelope of budding virions. We
suggest that FIP1C and Rab14 are required for this directed
trafficking from the ERC to the site of particle assembly and
budding, as depicted in Fig. 8. This model predicts that cellular
levels of specific trafficking factors may limit the number of Env
trimers incorporated onto particles. In support of this idea, we
were able to modestly increase the amount of Env on HIV
particles by overexpression of constitutively-active Rab14. We
propose that the delivery of Env trimers to the cell surface is
required but not sufficient for particle incorporation for wildtype
viruses bearing intact CTs. Truncated Env constructs such as
CT144 reach the cell surface of permissive cells and may be
acquired passively, explaining the lack of saturation of truncated
Env shown in Fig. 1 of this report. However, T cells are not
permissive for incorporation of truncated Env [23]. Therefore the
nature of the assembly microdomain in which assembly occurs
may differ between cell types such as HeLa cells and H9 cells, with
exclusion of truncated Env from this microdomain in H9 cells and
lack of exclusion in HeLa. Active trafficking of full length Env,
directed by Rab14 and FIP1C, is required for Env delivery and
particle incorporation in both cell types. The tail dependence of
this phenotype predicts that specific motifs in the CT will be
engaged with a FIP1C/Rab14 complex in the outward trafficking
of Env. Future work will focus on the identification of these motifs
and the interacting domains within FIP1C. We note that there
are numerous polymorphisms in FIP1C alleles reported in the
NCBI database, some of which could be damaging to its function.
It will be important in future studies to examine the potential
leftmost lanes set to 100. (B) shRNA-mediated depletion of Rab11 or Rab14 was performed in HeLa cells. Following selection in puromycin, cells were
transfected with either pNL4-3 or pNL4-3 CT144 plasmid. Cellular and particle-associated Env was detected by immunoblotting 48 hours following
transfection. (C) shRNA-resistant GFP-FIP1C* WT and GFP-FIP1C* (S580N/S582L) were transfected together with pNL4-3 in control HeLa cells or FIP1C-
depleted HeLa cells as in the repletion experiment described in Figure 2. Input FIP1C* plasmid levels were 2 mg in lanes 3, 5, 7, and 8 and increased to
4 mg in lanes 4 and 6. In a separate experiment the ability of Rab11 binding mutant GFP-FIP1C* I62E and GFP-FIP1C* D622N to rescue Env particle
incorporation in FIP1C-depleted HeLa cells (lanes 7 and 8). Note that gp160 and gp120 were detected with polyclonal antiserum; gp41 particle blots
were probed with a monoclonal specific for gp41.
doi:10.1371/journal.ppat.1003278.g006
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Figure 7. FIP1C is required for Env incorporation in MDMs and enhances Env content of HIV-1 particles when overexpressed with
Rab14. (A) MDMs were prepared from peripheral blood of healthy donors and depleted of FIP1C using two administrations of siRNA. MDMs were
then infected with VSV-G-pseudotyped NL4-3 or NL4-3delCT144. Cell lysates and purified particles were examined 8 days following infection. Shown
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effect of polymorphisms in FIP1C on HIV acquisition or disease
progression.
In conclusion, we have identified for the first time a complex of
Rab14 and Rab11-FIP1C with a biologically-relevant cargo. The
Rab14/FIP1C complex directs HIV-1 Env to the plasma
membrane assembly site for incorporation onto developing
particles in a manner that depends upon the long cytoplasmic
tail of Env. It will be of great interest to define other components
of this trafficking complex, such as motor protein(s) involved in the
outward trafficking of Env, and to extend these findings to the




Peripheral blood was obtained from healthy volunteer donors
according to a protocol approved by the Emory University
Institutional Review Board (IRB). Written informed consent was
obtained from donors, and samples were de-identified prior to
handling by laboratory personnel.
Cells and media
HeLa and TZM-bl cells [57]) were maintained in DMEM
containing 10% FBS and antibiotics. The H9 T cell line (ATCC
HTB-176) were cultured in RPMI medium 1640 supplemented
with 10% FBS, 2 mM Glutamine, and antibiotics. MDMs were
prepared from human peripheral blood as described previously
[29]. HeLa T-REX cells for inducible expression of FIP1C and
Rab14 were created using the T-REx system and vector
pCDNA5/TO (Invitrogen). Cells were maintained in tetracy-
cline-free media and induction carried out with 1 mg/ml
doxycycline.
Viruses, plasmids, and lentiviral vectors
Vesicular stomatitis virus G glycoprotein (VSV-G)-pseudotyped
HIV-NL4.3 and HIV-CT144 virus stocks were generated by
cotransfecting 293T cells with pNL4.3 or pNL4.3CT144 and the
VSV-G expression plasmid pHCMV-G. Viruses were harvested
from transfected 293T supernatants 48 hours post-transfection,
filter-sterilized, and assayed with TZM-bl indicator cells for
infectivity assessment. Env expression plasmids pIIINL4env and
are Western blot results from two donors. (B) Particle infectivity from the experiments described above was measured in TZM-bl reporter cells as
before. (C) Parental HeLa T-REx cells (Invitrogen) and HeLa-T-REx cells stably transfected with plasmids for inducible expression of FIP1C and
Rab14Q70L were transfected with a constant amount of Gag expression plasmid and increasing amounts of NL4-3 Env plasmid (numbers above
gp160 blot represent mg of input plasmid). Cell lysates and purified particles were examined by Western blotting. In these experiments, virus lanes
were loaded with equal amounts of p24 as measured by ELISA. The bottom Env immunoblot represents cell surface Env as determined by
biotinylation and precipitation with streptavidin beads, using the same input Gag and Env DNA as above. (D) Env and Gag content of released viral
particles was quantified by densitometry using the LiCor instrument and plotted as background-subtracted Env pixel intensity to Gag pixel intensity
(left) and by p24 and gp120 antigen-capture ELISA (right). The number of Env molecules per particle was calculated as an approximation, assuming
that 5000 CA molecules are present in one HIV-1 virion.
doi:10.1371/journal.ppat.1003278.g007
Figure 8. Model for outward sorting of HIV Env by the FIP1C-Rab14 complex. ERC= endosomal recycling compartment.
doi:10.1371/journal.ppat.1003278.g008
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pIIINL4envCTdel-144 were gifts kindly provided by Dr. Eric
Freed [23]. Vesicular stomatitis virus glycoprotein (VSV-G)
expressing plasmid pHCMV-G was provided by J. Burns [58].
Amphotropic MLV Env expression vector pCL-Ampho was from
Inder Verma [56]. Rab11a expression plasmids and FIP1C
expression plasmids have been previously described [24,26,59].
FIP1C-specific shRNA constructs and methods, siRNA sequences,
and real-time PCR reagents are described in Supplemental
Experimental Procedures. Silencing of FIP1C-expression in
MDMs was carried out by transfecting FIP1C-specific siRNA
(Dharmacon) using the N-TER nanoparticle siRNA transfection
system (Sigma) as previously described [29].
Antibodies and immunostaining reagents
Rabbit polyclonal antibody against FIP1C was obtained from
Sigma. Goat polyclonal antibody against HIV-1 gp120 and gp160
(used in Western blotting) was AHP2204 from AbD Serotec
(Oxford, UK). Human anti-gp120 antibody for immunofluores-
cence experiments was IgG1 b12; synthesized from recombinant
cDNA by the laboratory of James Crowe (Vanderbilt University).
Antibody used for immunoblotting of gp41 was murine monoclo-
nal 5009 from BTI research reagents (Columbia, MD). HIV Gag
detection was performed with either rabbit anti-p17 polyclonal,
mouse anti-p24 monoclonal CA-183 (provided by Bruce Chesebro
and Kathy Wehrly through the NIH AIDS Research and
Reference Reagent Program), or mouse anti-p24-FITC (KC57-
FITC) obtained from Beckman Coulter (Fullerton, CA, USA).
Anti-VSV-G antibody was from Sigma (V5507), and anti-
amphotropic MLV goat antiserum (679) was obtained from Chris
Aiken (Vanderbilt). Rabbit anti-Rab14 antibody was obtained
from Aviva Systems Biology. Mouse monoclonal anti-Rab11a
(8H10) was described previously by the Goldenring laboratory
[60], who also provided rabbit anti-Rab11b polyclonal antiserum
(VU76). Alexa Fluor goat anti-mouse and Alexa Fluor goat anti-
rabbit secondary antibodies, as well as the DAPI nucleic acid stain
were obtained from Molecular Probes (Eugene, OR, USA). IRDye
goat anti-mouse and IRDye goat anti-rabbit secondary antibodies
used for Western blots were obtained from Li-cor Biosciences
(Lincoln, NE, USA).
Image acquisition and analysis
Images of GFP-FIP1C and Env distribution were obtained with
a Nikon TE2000-U spinning disc confocal fluorescence micro-
scope with automated stage and Hamamatsu EM-CCD camera
developed by Improvision under the control of the Volocity
software, or with a DeltaVision imaging system developed by
Applied Precision. The system was equipped with an Olympus
IX70 microscope and a CoolSnap HQ2 digital camera under the
control of the softWoRx software. Imaging processing and
deconvolution was performed using softWoRx 3.7.0. Colocaliza-
tion measurements were quantified with the colocalization
function of Volocity 5.2.1. For immunofluorescence experiments,
HeLa cells were washed with PBS and fixed in 4% paraformal-
dehyde for 12 minutes at RT. After fixation, cells were extensively
washed including an overnight wash at 4 degree. Cells were then
permeabilized for 10 minutes with 0.2% Triton X-100 and block
in Dako blocking buffer for 30 minutes. Primary and secondary
antibodies were diluted in Dako antibody diluent to appropriate
concentrations. DAPI was used to stain the nuclei of the cells. The
coverslips were mounted in Gelvatol overnight and examined
directly the next day. Images of endogenous Rab11 and Rab14
together with GFP-FIP1C were obtained using an Olympus
Fluoview confocal microscope; details of immunofluorescence
staining protocols and antibodies for these experiments are
provided in Supplemental Experimental Procedures.
Flow cytometry for HIV-1 Env
HeLa and H9 surface staining was performed with human
monoclonal anti-gp120 antiserum at final concentration of 0.1 ug/
ml in PBS with 2% BSA and a second PE-conjugated anti-human
antibody at 0.02 ug/ml. Mouse anti-p24-FITC (KC57-FITC,
Beckman-Coulter) was employed following permeabilization to
allow gating on the infected population. HeLa cells were harvested
at 48 hours post-infection in this analysis, while H9 cells were
harvested at day 4 post-infection. Analysis was performed on a
FACSCanto flow cytometer (BD Biosciences) and using FlowJo
software (Treestar, Inc).
Virus release assays and infectivity assays
At 48 hours post transfection, virion- containing culture
supernatants were harvested, clarified by low speed centrifugation
and filtered (0.2 mm). Infectious virus release was determined by
inoculating TZM-bl indicator cells, plated the previous day in 12
well plates at 16105 cells/well, with 400 ml of serially diluted
supernatants. At 48 hours after infection, cells were fixed and
stained with X-gal. Blue cells were counted and infectivity was
calculated as blue cell numbers per nanogram of p24 inoculation.
The remainder of the virion containing supernatant (750 ml) was
layered onto 200 ml of 20% sucrose in PBS and centrifuged at
20,000 g for 2 hours at 4uC. Virion pellets, and corresponding
virion producing cells were dissolved in SDS PAGE loading buffer.
Virion and cell lysates were separated on 10% polyacrylamide gels
and subjected to Western blotting.
Supporting Information
Figure S1 Env vs. Env + Gag pelleting. In order to confirm
that overexpression of Env was not leading to pelletable Env in the
absence of Gag, we performed a titration of Env expression in HeLa
cells without (left) or with (right) a constant amount of Gag expression.
Supernatant materials were pelleted through 20% sucrose cushions
and analyzed by Western blotting for the proteins shown.
(TIF)
Figure S2 Recycling factor involvement in Env incorpo-
ration. A) Rab11a or Rab11b depletion does not alter Env
incorporation. shRNA-mediated depletion of Rab11b (center
lanes) or Rab11a (right lanes) was performed in HeLa cells,
followed by expression of NL4-3 provirus. Cell lysates (left lanes)
and pelleted viral particles (right) were analyzed by Western
blotting for the indicated proteins. B) Overexpression of
Rab11aS20V depletes particle-associated Env and leads to
degradation of cellular Env. An expression plasmid for Rab11a
S20V was titrated in HeLa cells co-expressing NL4-3 (left) or NL
CT144 (right). Cellular Env levels and particle-associated Env
were evaluated by Western blot. Full-length Env was depleted by
S20V, while truncated Env was unaffected.
(TIF)
Figure S3 Effect of Rab11-FIP1C/RCP depletion on HIV
particle pseudotyping with amphotropic MLV and VSV-
G. (A) The effect of FIP1C/RCP depletion on amphotropic MLV
Env (middle panel) and VSV-G protein (lower panel) incorpora-
tion onto HIV-1 particles was examined and compared with
effects on gp120 particle incorporation (top). (B) Infectivity of
pseudotyped viruses from (A) was measured using TZM-bl
reporter cells; units are infected cells/ng p24 input.
(TIF)
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Figure S4 Rab14 does not associate with Rab11-FIP2.
HeLa cells were transfected with either (A) wild type GFP-
Rab11-FIP2 or (B) GFP-FIP2 (129–512), designated FIP2(DC2).
Cells were fixed and then immunostained for endogenous Rab14
and endogenous Rab11a. Inserts show higher magnification
regions. Note that FIP2(DC2) strongly concentrated Rab11a in
association with the EGFP-chimera, but had no effect on Rab14
distribution.
(TIF)
Figure S5 Co-immunoprecipitation of FIP1C with
Rab14. HeLa Cells were transfected with EGFP-FIP1C WT or
EGFP-FIP1C (S580N/S582L) and EGFP-Rab14. Input protein
content is shown on left. IP was performed using FIP1C-specific
antisera, followed by immunoblotting for the proteins indicated on
the right. Endogenous Rab11a is shown.
(TIF)
Figure S6 Rab14 enhancement of HIV-1 Env incorpora-
tion requires FIP1C and Rab14 depletion does not alter
incorporation of MLV or VSV-G Env. A) Titration of
Rab14Q70L in HeLa cells with normal FIP1C levels (Scr shRNA
lanes) or in cells depleted of FIP1C (FIP1C shRNA lanes). Note
that gp120 and gp160 blots were probed with goat anti-gp120/
gp160 antisera, while gp41 was probed with murine monoclonal
anti-gp41 antibody. B) Hela cells were transfected with NL4-3 or
with NL4-3deltaEnv and expression constructs pHCMV-G (for
VSV-G) or pCL-Ampho (MLV Env). Depletion of Rab14 was
performed using shRNA in the indicated lanes. Cellular and
particle Env content was assessed by immunoblotting with specific
antisera for HIV gp120/160, VSV-G, or amphotropic MLV Env.
(TIF)
Text S1 1) Table S1: Split-ubiquitin yeast two-hybrid assay of
Rab11-FIP protein interaction with Rab proteins. Split ubiquitin
assays were performed between CCW vectors with Rab11-FIP
proteins and DSL vectors with Rab proteins. Results were
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